In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish … Learn more
In this episode, we will be hearing from Dr. Suzanne Cuda, President and Medical Director for Alamo City Healthy Kids and Families. Joining her is Nancy Browne and Dr. Valarie O’Hara. Nancy is a nurse practitioner, pediatric obesity medicine specialist … Learn more
In this episode, Obesity Medicine Association (OMA) Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Shagun Bindlish, MD. Our experts discuss a series of clinical practice statements recently published in ‘Obesity Pillars’, for which Dr. Bindlish … Learn more
In this episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings and Dr. Robert Lustig, discuss non-alcoholic fatty liver disease and obesity. Dr. Lustig is a professor of pediatric in the division of endocrinology at UCSF. In … Learn more
In this three part series, Dr. Harold Bays and Dr. Tiffany Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Learn more
Dr. Nick Pennings and Dr. Andreas Acosta discuss the importance of aligning appropriate lifestyle interventions to each of the four key types of obesity phenotypes. Learn more
In this three part series, Dr. Harold Bays and Dr. Tiffany Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Learn more
Dr. Nick Pennings and Dr. John J. Kissick discuss the importance of physical activity in weight management and overall health. Learn more
Dr. Nick Pennings discusses recognizing and treating Lipedema with Dr. Karen Herbst. Learn more
In this three part series, Dr. Harold Bays and Dr. Tiffany Lowe-Clayton review the article: Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023. Topics in this episode include the proper prescribing of medications for the treatment of obesity and diabetes including GLP1agonists and SGLT2 inhibitors. Learn more